| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 |
| filingDate |
2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48bac9f91def18865ec4cbf9b7428095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38d555534a4ee96b9cf376ab09efb2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1306460a967b76e71a82955f89bac26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9eb7f79bfaf902be4001d351511e118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0363ffe693f54af9f581e0d307c52923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b60e1b88676ef8718caf10d5ae57c2f |
| publicationDate |
2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017163808-A1 |
| titleOfInvention |
Compound or salt thereof, natural killer t cell activator, and pharmaceutical composition |
| abstract |
The present invention addresses the problem of providing: a novel compound capable of activating a natural killer T cell, or a salt of the compound; a natural killer T cell activator comprising the compound or a salt thereof; and a pharmaceutical composition.nThe compound according to the present invention is a compound represented by formula (1) or a salt thereof. It is preferred that the sum total of the number of carbon atoms excluding carbon atoms in a substituent in a monovalent hydrocarbon group in R 1 and the number of carbon atoms in a bivalent hydrocarbon group in X 1 in formula (1) is 5 to 50. The natural killer T cell activator comprises the compound or a salt thereof. The pharmaceutical composition contains the compound or a pharmacologically acceptable salt thereof. |
| priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |